Cadila Healthcare informs about press release

02 May 2020 Evaluate

Cadila Healthcare has informed that the company enclosed a Press Release dated May 2, 2020 titled ‘Zydus receives tentative approval from the USFDA for Empagliflozin and Metformin Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

916.35 2.50 (0.27%)
19-Dec-2025 11:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1747.40
Dr. Reddys Lab 1281.60
Cipla 1509.50
Zydus Lifesciences 916.35
Lupin 2128.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×